Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment

C. Meazza, H. H. Elsedfy, S. Pagani, E. Bozzola, M. El Kholy, M. Bozzola

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

It is a common knowledge that GH exhibits a large number of metabolic effects, involving lipid and glucose homeostasis. The aim of the study was to investigate the effect of one year GH therapy on metabolic parameters and adipokines in GH deficient (GHD) children. Sixteen prepubertal children (11 M and 5 F) with complete GHD (age range: 3.4-14.7 years) and 20 (13 M and 7 F) age and sex-matched healthy children (age range: 4.6-12.3 years) were studied. Blood was collected from patients before starting GH therapy (0.025 mg/kg/day) and one year later, and from healthy children to measure adiponectin, leptin, osteoprotegerin, resistin, interleukin (IL)-6, tumor necrosis factor (TNF)-α levels, and other glucose and lipid metabolism parameters. Adiponectin and resistin levels were significantly higher (49 980 ng/ml vs. 14 790 ng/ml and 11.0 pg/ml vs. 6.3, respectively) in GHD children before GH therapy than in controls. Serum IGF-I levels (p=0.0001) and height SDS (p

Original languageEnglish
Pages (from-to)219-223
Number of pages5
JournalHormone and Metabolic Research
Volume46
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Resistin
Adipokines
Adiponectin
Growth Hormone
Osteoprotegerin
Glucose
Leptin
Insulin-Like Growth Factor I
Interleukin-6
Blood
Tumor Necrosis Factor-alpha
Lipids
Therapeutics
Lipid Metabolism
Homeostasis
Serum
5,6-dihydroxy-2-dimethylaminotetralin

Keywords

  • adipokines
  • children
  • GH deficiency
  • GH therapy
  • metabolism

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment. / Meazza, C.; Elsedfy, H. H.; Pagani, S.; Bozzola, E.; El Kholy, M.; Bozzola, M.

In: Hormone and Metabolic Research, Vol. 46, No. 3, 2014, p. 219-223.

Research output: Contribution to journalArticle

@article{c2c821ef51d04ae8a16ebd4d3216e717,
title = "Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment",
abstract = "It is a common knowledge that GH exhibits a large number of metabolic effects, involving lipid and glucose homeostasis. The aim of the study was to investigate the effect of one year GH therapy on metabolic parameters and adipokines in GH deficient (GHD) children. Sixteen prepubertal children (11 M and 5 F) with complete GHD (age range: 3.4-14.7 years) and 20 (13 M and 7 F) age and sex-matched healthy children (age range: 4.6-12.3 years) were studied. Blood was collected from patients before starting GH therapy (0.025 mg/kg/day) and one year later, and from healthy children to measure adiponectin, leptin, osteoprotegerin, resistin, interleukin (IL)-6, tumor necrosis factor (TNF)-α levels, and other glucose and lipid metabolism parameters. Adiponectin and resistin levels were significantly higher (49 980 ng/ml vs. 14 790 ng/ml and 11.0 pg/ml vs. 6.3, respectively) in GHD children before GH therapy than in controls. Serum IGF-I levels (p=0.0001) and height SDS (p",
keywords = "adipokines, children, GH deficiency, GH therapy, metabolism",
author = "C. Meazza and Elsedfy, {H. H.} and S. Pagani and E. Bozzola and {El Kholy}, M. and M. Bozzola",
year = "2014",
doi = "10.1055/s-0033-1358730",
language = "English",
volume = "46",
pages = "219--223",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment

AU - Meazza, C.

AU - Elsedfy, H. H.

AU - Pagani, S.

AU - Bozzola, E.

AU - El Kholy, M.

AU - Bozzola, M.

PY - 2014

Y1 - 2014

N2 - It is a common knowledge that GH exhibits a large number of metabolic effects, involving lipid and glucose homeostasis. The aim of the study was to investigate the effect of one year GH therapy on metabolic parameters and adipokines in GH deficient (GHD) children. Sixteen prepubertal children (11 M and 5 F) with complete GHD (age range: 3.4-14.7 years) and 20 (13 M and 7 F) age and sex-matched healthy children (age range: 4.6-12.3 years) were studied. Blood was collected from patients before starting GH therapy (0.025 mg/kg/day) and one year later, and from healthy children to measure adiponectin, leptin, osteoprotegerin, resistin, interleukin (IL)-6, tumor necrosis factor (TNF)-α levels, and other glucose and lipid metabolism parameters. Adiponectin and resistin levels were significantly higher (49 980 ng/ml vs. 14 790 ng/ml and 11.0 pg/ml vs. 6.3, respectively) in GHD children before GH therapy than in controls. Serum IGF-I levels (p=0.0001) and height SDS (p

AB - It is a common knowledge that GH exhibits a large number of metabolic effects, involving lipid and glucose homeostasis. The aim of the study was to investigate the effect of one year GH therapy on metabolic parameters and adipokines in GH deficient (GHD) children. Sixteen prepubertal children (11 M and 5 F) with complete GHD (age range: 3.4-14.7 years) and 20 (13 M and 7 F) age and sex-matched healthy children (age range: 4.6-12.3 years) were studied. Blood was collected from patients before starting GH therapy (0.025 mg/kg/day) and one year later, and from healthy children to measure adiponectin, leptin, osteoprotegerin, resistin, interleukin (IL)-6, tumor necrosis factor (TNF)-α levels, and other glucose and lipid metabolism parameters. Adiponectin and resistin levels were significantly higher (49 980 ng/ml vs. 14 790 ng/ml and 11.0 pg/ml vs. 6.3, respectively) in GHD children before GH therapy than in controls. Serum IGF-I levels (p=0.0001) and height SDS (p

KW - adipokines

KW - children

KW - GH deficiency

KW - GH therapy

KW - metabolism

UR - http://www.scopus.com/inward/record.url?scp=84895524971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895524971&partnerID=8YFLogxK

U2 - 10.1055/s-0033-1358730

DO - 10.1055/s-0033-1358730

M3 - Article

VL - 46

SP - 219

EP - 223

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 3

ER -